GL1X · GenesisL1 explorer

Research workbench

Human pd-L1 bound to a macrocyclic peptide which blocks the pd-1/PD-L1 interaction

Analyse Human pd-L1 bound to a macrocyclic peptide which blocks the pd-1/PD-L1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PV9
Type
protein
Length
220 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Programmed cell death 1 ligand 1; Macrocyclic peptide
UniProt
Q9NZQ7
Ligands
ACE, NH2

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProgrammed cell death 1 ligand 1protein2058% helix, 53% strandQ9NZQ7
BMacrocyclic peptideprotein150% helix, 27% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B
  • NH2 · Amino group · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 633 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified, 2 covalent, 2 disulfide, 1 d-amino (nonstandard, covalent ligand, disulfide, D-amino acid, methylation).

Compared structures

  • 6PV9 · Human PD-L1 bound to a macrocyclic peptide which blocks the PD-1/PD-L1 interaction · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.